Ximena Aguilar
Senior research engineer at Department of Public Health and Caring Sciences; Molecular Geriatrics / Rudbeck laboratory
- Telephone:
- +46 18 471 50 30
- Mobile phone:
- +46 73 469 74 54
- E-mail:
- ximena.aguilar@pubcare.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
- Postal address:
- Rudbecklaboratoriet
751 85 Uppsala

Publications
Recent publications
-
Part of Journal of Nuclear Medicine, p. 463-470, 2026
- DOI for Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti–Amyloid-β Antibody
- Download full text (pdf) of Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti–Amyloid-β Antibody
-
PET imaging of TREM2 in amyloid-beta induced neuroinflammation
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 4320-4333, 2025
- DOI for PET imaging of TREM2 in amyloid-beta induced neuroinflammation
- Download full text (pdf) of PET imaging of TREM2 in amyloid-beta induced neuroinflammation
-
Updated transient gene expression protocol in Expi293F cells using PEI
Part of Frontiers in Bioengineering and Biotechnology, 2025
- DOI for Updated transient gene expression protocol in Expi293F cells using PEI
- Download full text (pdf) of Updated transient gene expression protocol in Expi293F cells using PEI
-
Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
Part of The Journal of Prevention of Alzheimer's Disease, 2025
- DOI for Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
- Download full text (pdf) of Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
-
Part of EJNMMI Radiopharmacy and Chemistry, 2025
- DOI for Brain-penetrating peptide and antibody radioligands for proof-of-concept PET imaging of fibrin in Alzheimer's disease
- Download full text (pdf) of Brain-penetrating peptide and antibody radioligands for proof-of-concept PET imaging of fibrin in Alzheimer's disease
All publications
Articles in journal
-
Part of Journal of Nuclear Medicine, p. 463-470, 2026
- DOI for Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti–Amyloid-β Antibody
- Download full text (pdf) of Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti–Amyloid-β Antibody
-
PET imaging of TREM2 in amyloid-beta induced neuroinflammation
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 4320-4333, 2025
- DOI for PET imaging of TREM2 in amyloid-beta induced neuroinflammation
- Download full text (pdf) of PET imaging of TREM2 in amyloid-beta induced neuroinflammation
-
Updated transient gene expression protocol in Expi293F cells using PEI
Part of Frontiers in Bioengineering and Biotechnology, 2025
- DOI for Updated transient gene expression protocol in Expi293F cells using PEI
- Download full text (pdf) of Updated transient gene expression protocol in Expi293F cells using PEI
-
Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
Part of The Journal of Prevention of Alzheimer's Disease, 2025
- DOI for Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
- Download full text (pdf) of Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
-
Part of EJNMMI Radiopharmacy and Chemistry, 2025
- DOI for Brain-penetrating peptide and antibody radioligands for proof-of-concept PET imaging of fibrin in Alzheimer's disease
- Download full text (pdf) of Brain-penetrating peptide and antibody radioligands for proof-of-concept PET imaging of fibrin in Alzheimer's disease
-
Antibody engagement with amyloid‐beta does not inhibit [11C]PiB binding for PET imaging
Part of Journal of Neurochemistry, p. 2601-2610, 2024
- DOI for Antibody engagement with amyloid‐beta does not inhibit [11C]PiB binding for PET imaging
- Download full text (pdf) of Antibody engagement with amyloid‐beta does not inhibit [11C]PiB binding for PET imaging
-
Part of Acta neuropathologica communications, 2024
- DOI for Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
- Download full text (pdf) of Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
-
Part of Molecular Therapy Nucleic Acids, p. 450-461, 2022
- DOI for CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN1 M146L mutation
- Download full text (pdf) of CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN1 M146L mutation
-
Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size
Part of Fluids and Barriers of the CNS, 2021
- DOI for Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size
- Download full text (pdf) of Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size
-
Long-Term Effects of Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease
Part of Journal of Alzheimer's Disease, p. 161-180, 2019
- DOI for Long-Term Effects of Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease
- Download full text (pdf) of Long-Term Effects of Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease
-
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease
Part of Molecular Imaging and Biology, p. 605-614, 2018
- DOI for Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease
- Download full text (pdf) of Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease
Articles, review/survey
-
PET Imaging in Preclinical Anti-Aβ Drug Development
Part of Pharmaceutical research, p. 1481-1496, 2022
- DOI for PET Imaging in Preclinical Anti-Aβ Drug Development
- Download full text (pdf) of PET Imaging in Preclinical Anti-Aβ Drug Development